From The Lab

An Inside Look at Germany’s Cannabis Supply Chain With The Grünhorn Group

On April 1, 2024, Germany launched Pillar 1 of its adult-use legalization framework, building on its established medical cannabis program that has been in place since 2017. Since then, the number of medical patients has surged, as prescriptions remain the only fully legal access point for cannabis aside from home cultivation or membership in non-commercial…

Continue reading

Hop Latent Viroid (HLVd) & Pathogen Diagnostics: A Comprehensive Overview

By Tassa Saldi, Ph.D.
1 Comment

Hop Latent Viroid (HLVd) threatens cannabis crops and results in reduced yield, quality and profit. However, the lack of education and research about this pathogen poses a bigger threat to the cannabis community. To safeguard the productivity and quality of cannabis crops we must learn accurate and timely pathogen identification along with proactive disease management practices.

Continue reading

A Research Study on the Antimicrobial Properties of Cannabis

By Cindy Orser, PhD
1 Comment

In this comprehensive scientific study, researchers use in vitro methods to evaluate the impact of products containing CBD and CBG on the most dominant vaginal lactobacilli species, L. crispatus, associated with good health. Given the rise of intimate care products marketed with CBD and the reported antimicrobial properties of cannabis, these scientists set out to learn if products like cannabis infused lube have any effect on a vaginal microbiome.

Continue reading